Clinical Trial Update: Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Vicagrel in patients with Acute Coronary Syndrome undergoing percutaneous coronary intervention, currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Vicagrel (vicagrel)

Snippet

Sponsor: Jiangsu vcare pharmaceutical technology co., LTD | Conditions: Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) | Phase 3 | Status: RECRUITING